QSC ships research-grade survodutide (BI 456906) to Australia. Survodutide is a dual GLP-1R/GCGR agonist — activating both the GLP-1 receptor (appetite, insulin) and the glucagon receptor (hepatic fat oxidation, thermogenesis). Phase 2 NASH trial data available.
≥99% HPLC purity · MS confirmed · Janoshik COA (verify at verify.janoshik.com). Shipping: International, 7-14 business days. Research use only.
Research Use Only. For in vitro laboratory research only. Not for human use.
